5-Acetylsalicylamide,
5-Acetyl-2-hydroxybenzamide,
40187-51-7,
Benzamide, 5-acetyl-2-hydroxy-,
5-Acetyl-2-hydroxy-benzamide,
5-Acetyl salicylamide,
BRN 3258263,
EINECS 254-830-5,
LWAQTCWTCCNHJR-UHFFFAOYSA-N,
MFCD00049222,
AK-25927,
W-106381,
ACMC-1ALB7,
5-Acetylsalicylamide, 98%,
DSSTox_CID_31525,
DSSTox_RID_97410,
DSSTox_GSID_57736,
4-10-00-03635 (Beilstein Handbook Reference),
SCHEMBL322274,
AC1L54W2,
5-ethanoyl-2-oxidanyl-benzamide,
CHEMBL3186004,
DTXSID2057736,
CTK1D5921,
KS-00000JDA,
ZINC154551,
BB_SC-07121,
EBD43407,
ZX-AT022774,
Tox21_113835,
ANW-29315,
BBL011499,
SBB056654,
STL146611,
AKOS005721143,
ACN-050911,
FCH1117357,
MCULE-4627686554,
RP24048,
ACM40187517,
NCGC00253716-01,
AJ-13308,
CC-21046,
DS-10628,
LS-25216,
SY048818,
ZB005819,
AX8020663,
CAS-40187-51-7,
DB-049546,
RT-001611,
A1156,
CS-0068949,
FT-0619937,
ST24029305,
ST50406048,
MFCD00049222 (98%),
A824965,
C-06517,
SR-01000944780,
SR-01000944780-1,
BRD-K97742629-001-01-5,
InChI=1/C9H9NO3/c1-5(11)6-2-3-8(12)7(4-6)9(10)13/h2-4,12H,1H3,(H2,10,13,
5-ASA,
C9H9NO3,
C9-H9-N-O3,
CID198212,